HemaSphere
(Mar 2022)
Limitations of Monitoring Disease Progression Using Circulating Tumor DNA in Lymphoma: An Example From Primary Cutaneous DLBCL Leg-type
- Christopher S. Trethewey,
- Harriet S. Walter,
- Abdullah N. M. Alqahtani,
- Ralf Schmid,
- David S. Guttery,
- Yvette Griffin,
- Matthew J. Ahearne,
- Gerald S. Saldanha,
- Sandrine P. N. Jayne,
- Martin J. S. Dyer
Affiliations
- Christopher S. Trethewey
- 1 Ernest and Helen Scott Haematological Research Institute, Leicester Cancer Research Centre, University of Leicester, United Kingdom
- Harriet S. Walter
- 1 Ernest and Helen Scott Haematological Research Institute, Leicester Cancer Research Centre, University of Leicester, United Kingdom
- Abdullah N. M. Alqahtani
- 1 Ernest and Helen Scott Haematological Research Institute, Leicester Cancer Research Centre, University of Leicester, United Kingdom
- Ralf Schmid
- 4 Department of Molecular and Cell Biology, University of Leicester, United Kingdom
- David S. Guttery
- 2 Leicester Cancer Research Centre, University of Leicester, United Kingdom
- Yvette Griffin
- 3 University Hospitals of Leicester NHS Trust, Leicester, United Kingdom
- Matthew J. Ahearne
- 1 Ernest and Helen Scott Haematological Research Institute, Leicester Cancer Research Centre, University of Leicester, United Kingdom
- Gerald S. Saldanha
- 2 Leicester Cancer Research Centre, University of Leicester, United Kingdom
- Sandrine P. N. Jayne
- 1 Ernest and Helen Scott Haematological Research Institute, Leicester Cancer Research Centre, University of Leicester, United Kingdom
- Martin J. S. Dyer
- 1 Ernest and Helen Scott Haematological Research Institute, Leicester Cancer Research Centre, University of Leicester, United Kingdom
- DOI
-
https://doi.org/10.1097/HS9.0000000000000690
- Journal volume & issue
-
Vol. 6,
no. 3
p.
e690
WeChat QR code